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immune responses is one that is just
beginning to be elucidated.
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The Notch2 ligand DL1 is required for marginal zone B cell development. In this issue of Immunity, Tan et al.
(2009) show thatmodification of Notch2 by Fringe enzymes is critical tomaturing B cells for accessing DL1 on
vascular endothelial cells.The two chief types of mature B cells
produced in adults are follicular and
marginal zone (MZ)Bcells.FollicularB cells
make up the bulk of peripheral B cells,
recirculate,and are the maincell type found
in the follicles of the splenic white pulp. In
contrast, MZ B cells are less abundant
and are actively retained within the MZ
located between the marginal sinus,
a main site for blood flow through the
spleen (Lu and Cyster, 2002; Pillai et al.,
2005), and the splenic red pulp. MZ B cells
play a pivotal role in host defense against
blood-borne bacterial pathogens, and
their localization near the blood-rich
marginal sinus is thought to be a key
component of this unique function (Pillai
et al., 2005).
One markedly incomplete puzzle for
B cell biologists is how immature B cells
are recruited into either the follicular or
the MZ B cell pools. Current data suggest
that this cell-fate decision is influenced by
a variety of extracellular inputs, including
signals derived from the B cell receptor
(BCR). A role for the BCR in the follicular
versus MZ B cell-fate decision is sup-
ported by experiments showing thatnewly formed B cells specific for certain
self antigens preferentially generate MZ
B cells (Martin and Kearney, 2000; Wen
et al., 2005), as well as by experiments
showing that mutation of the BCR
signaling machinery can markedly influ-
ence the follicular versus MZ B cell-fate
choice (Martin and Kearney, 2000).
MZ B cells are also unique among
B-lineage cells in that their propagation is
highly dependent on signals provided by
the Notch family of cell-surface receptors.
In mammals, the Notch family contains
four different receptors (Notch1–4) and at
least five different ligands, including three
members of the Delta-like (DL) family (DL1,
DL3, and DL4) and two members of the
Serrate family (Jagged-1 and Jagged-2)
(Maillard et al., 2005). Engagement of
Notch receptors by ligands activates the
proteolytic release of the intracellular
Notch domain (ICN) from the cell
membrane. Consequently, ICN migrates
to the nucleus, where it interacts with the
transcription factor CSL and the transcrip-
tional coactivator MAML1 to promote the
expression of a wide and largely unknown
collection of genes.Immunity 30,Interestingly, although Notch1-DL4
interactions regulate a variety of differ-
entiation events within the T cell lineage,
MZ B cell development specifically
requires Notch2 and DL1 (Hozumi
et al., 2004; Saito et al., 2003). Indeed,
mice lacking either Notch2 or DL1 fail
to generate MZ B cells but do not
exhibit defects in T cell development or
function. These findings raise several
fundamental questions about how,
when, and where immature peripheral
B cells are engaged by DL1 and whether
Notch2 is unique among Notch recep-
tors in its capacity for promoting MZ
B cell development.
In this issue of Immunity, Tan et al.
provide two much needed insights into
how immature B cells gain access to DL1
(Tan et al., 2009). First, they show that
optimal MZ B cell differentiation requires
modification of Notch2 by members of
the Fringe family of beta-1,3-N-acetylglu-
cosaminyltransferases. Second, and
perhaps especially surprising, they show
that constitutive DL1 expression in the
spleen is restricted to clusters of vascular
endothelial cells within the MZ and redFebruary 20, 2009 ª2009 Elsevier Inc. 175
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PreviewsFigure 1. Localization of DL1+ Vascular Endothelial Cells near Incoming Transitional B Cells
During peripheral B cell maturation, the least mature transitional B cells (T1 B cells) enter the spleen via the
marginal sinus before entering the marginal zone, where they must interact with DL1+ vascular endothelial
cells to become marginal zone B cells. The bulk of T1 B cells fail to adequately interact with DL1+ cells and
as a result give rise to more mature transitional B cells (T2 B cells), which in turn generate follicular B cells.
Elongated cells marked in blue represent DL1+ vascular endothelial cells.pulp of the spleen, on the outskirts of the
lymphocyte-rich splenic white pulp.
Notch proteins are modified exten-
sively during their biosythesis. Extracel-
lular Notch domains responsible for
ligand binding contain as many as 36
tandem epidermal growth factor (EGF)-
like repeats. In the Golgi, nascent Notch
proteins are subjected to O-fucosylation,
a specialized form of glycosylation that
adds O-linked fucose residues to many
EGF repeats (Stanley, 2007). In addition,
the Fringe enzymes can modify the
saccharide structure of O-fucose moie-
ties on Notch receptors, and these modi-
fications enhance binding of Delta-like
ligands to Notch receptors. In verte-
brates, there are three Fringe homologs,
named Lunatic, Manic, and Radical
Fringe. By examining peripheral B cell
subset distribution in cells derived from
Manic Fringe- and/or Lunatic Fringe-defi-
cient progenitors, Tan et al. show that
optimal MZ B cell development requires
the concerted activity of both Manic and
Lunatic Fringe. These data imply that
Notch ligand binding, and therefore
Notch activity, is tuned exquisitely during
peripheral B cell development via cell-
intrinsic biochemical events mediated by
both Lunatic and Manic Fringe. On the
basis of these results, it is tempting to
speculate that Manic and Lunatic Fringe
activity is promoted by extracellular
cues that serve to enhance the possibility
that immature B cells will successfully176 Immunity 30, February 20, 2009 ª2009engage DL1. Although thought on the
potential identity of such cues may
constitute additional speculation, we
suggest that the BCR is an attractive
candidate, given that this connection
would inform past demonstrations of
synergy between the BCR and Notch
signaling (Thomas et al., 2007) and
perhaps explain why BCR specificity
predisposes certain cells to enter the
MZ B cell pool.
Until now, the cell-cell interactions
required for Notch2-mediated MZ B cell
development were exceptionally myste-
rious. However, through histological anal-
ysis of spleens from DL1 reporter mice,
Tan et al. provide evidence that constitu-
tive DL1 expression in the spleen is
restricted to vascular endothelial cells.
These specialized DL1+ endothelial cells
are located in the MZ and the red pulp
but not, quite strikingly, within the lympho-
cyte-rich white pulp of the spleen
(Figure 1).
These findings provide several insights
into the spatial and temporal parameters
underlying DL1-mediated MZ B cell differ-
entiation. First, if one assumes that all
maturing B cells are equally likely to
encounter the various extracellular cues
required for MZ B cell differentiation, the
data of Tan et al. suggest that every imma-
ture B cell must come into close proximity
to DL1+ vascular endothelial cells in the
MZ and that these putative cell-cell inter-
actions directly influence the follicularElsevier Inc.versus MZ B cell fate. Second, given that
newly formed B cells first enter the spleen
as exceptionally immature cells
(commonly referred to as transitional
type-1 or ‘‘T1’’ B cells) and that DL1+
endothelial cells in the MZ are located in
close proximity to proposed splenic entry
sites, B cells within the T1 population
may be the main target of DL1-induced
MZ B cell differentiation. Notch2-stimu-
lated T1 B cells would then generate
MZ B cell precursors (MZPs) directly,
with cells failing to interact with DL1+
endothelial cells giving rise to more
mature transitional cells (‘‘T2’’ cells),
which may in turn yield follicular B cells
directly (Figure 1). This model is consis-
tent with additional data from Tan et al.
showing that expression of the canon-
ical Notch target gene Hes-1 is readily
observed within the T1 population, and
it contrasts with past models predicting
that the follicular versus MZ B cell-fate
decision occurs relatively late in periph-
eral B cell maturation.
It should be noted that past work
suggests that Jagged and Delta family
Notch ligands, including DL1, are ex-
pressed on a potentially broad range of
hematopoietic cells in the spleen. These
past studies, which employed a variety
of experimental approaches, including
mRNA transcript analyses of purified
cells and histological analyses using
ligand-specific antibodies, contrast with
the data of Tan et al., in which Notch
ligand expression was assayed exclu-
sively with ligand-specific reporter mice.
Although this discrepancy may reflect
differences in sensitivity of the various
assays employed, an alternative (and
perhaps more exciting) possibility is that
these differences reflect constitutive, as
opposed to induced, Notch ligand
expression. In this model, expression of
Notch ligands in the spleen can be
induced by a variety of extracellular
inputs, many of which may occur as
a consequence of infection or other anti-
genic stimulation. This view is consistent
with experiments showing that Toll-like
receptor stimulation induces Delta and
Jagged expression in dendritic cells
(Maillard et al., 2005). Therefore, Notch
ligand expression in peripheral lymphoid
organs such as the spleen may be highly
dynamic, providing yet another mecha-
nism whereby the immune system may
adapt to pathogenic insults. These
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understanding of the signals regulating
Fringe activity, should provide a more
comprehensive picture into how Notch
signaling regulates peripheral lymphocyte
development and differentiation.
In sum, the cellular and molecular
events that regulate the follicular and MZ
B cell-fate choice remain poorly under-
stood. Whether all immature B cells are
equally likely to gain access to the requi-
site signals, whether specific subsets of
maturing B cells receive such signals,
and how such signals are integrated to
induce the MZ B cell-fate are open ques-
tions. The data provided by Tan et al.
provide an important leap forward in ourThe Antigen Expre
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In this issue of Immunity, Roozenda
that allows transport of small antige
The intriguing question of how antigen is
delivered to follicular B cells to initiate
humoral immune responses has occupied
immunologists for more than four decades
(Nossal et al., 1968). In spite of this,
the mechanism by which B cells first
encounter antigen to initiate activation
in vivo remains somewhat enigmatic. It is
well established that these encounters
are localized to specialized secondary
lymphoid tissues, such as the lymph
nodes (LNs), as a means of increasing
the likelihood that B cells will encounter
cognate antigen. However, although the
LN is continually supplied with lymphatic
fluid through the afferent vessel, tight
packing of cells at the subcapsular sinus
(SCS) prevents the free diffusion of antigen
into the LN interior, raising the question of
how antigen can gain access to B cells
contained within follicles. Given the phys-understanding of these issues, especially
in the context of the role of Notch activity
in this process.
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iological importance of antigen-mediated
activation of B cells, considerable effort
has been invested in applying innovative
technologies to this complex biological
puzzle, and indeed, very recently these
have yielded a number of exciting solu-
tions (Batista and Harwood, 2009).
In this issue, Roozendaal et al. (2009)
substantially extend the understanding
of the B cell activation process in vivo by
revealing a mechanism by which follicular
B cells encounter antigen (Figure 1). This
current study builds on the foundation
laid by a group of four studies that were
published in 2007. The first of these
demonstrated that within minutes of injec-
tion, small soluble antigen diffuses directly
through the SCS, leading to activation of
follicular B cells according to their prox-
imity to the SCS (Pape et al., 2007). This
diffusion was suggested to occur through
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stem within the lymph node follicle
psular sinus to follicular B cells.
pores in the SCS that were detected in
earlier electron microscopy investigations.
Such a mechanism does not, however,
provide a route for larger antigens to gain
access to follicular B cells, indicating that
the strategy used for initiating B cell activa-
tion is tailored to the characteristics of the
antigen itself. Indeed, three subsequent
studies have revealed an alternative cell-
mediated mechanism by which follicular
B cellsencounter largerantigens (Carrasco
and Batista, 2007; Junt et al., 2007; Phan
et al., 2007). These investigations moni-
tored the spatiotemporal dynamics of
follicular B cells within the LN relative to
particulate antigens, immune complexes,
or viruses with multiphoton microscopy.
Each of these larger antigens was rapidly
localized at the SCS, where macrophages
can present the antigen and mediate the
retention of specific B cells. Subsequently,
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